CFO of Harmony Biosciences Uses 10b5‑1 Plan to Sell 3,746 Shares, Market Reacts Mildly.
Harmony Biosciences CFO’s 3,746‑share sale under a 10b5‑1 plan is routine portfolio rebalancing, not a bearish signal for investors.
- Harmony Biosciences Holdings Inc
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read